Paper Title
DLQI and PASI in patients of psoriasis attending tertiary care centre.
Article Identifiers
Authors
Dr.Awani Kansagra , Dr Vishal Patel , Dr Kishor Singh , Dr Kavita Choudhary , Dr U.S.Agarwal
Keywords
Psoriasis, PASI, DLQI
Abstract
Abstract: Background: Psoriasis is a chronic, immune mediated, inflammatory and proliferative cutaneous disorder characterized by well defined, erythematous, scaly, indurated plaques on extensor aspect of body and scalp. It has got a very significant deleterious effect on the quality of life (QOL). The severity of disease in psoriasis is assessed by measurement of body surface area; although there are other postulates which argue that, quality of life (QOL) would be a better method of assessing the severity of disease in psoriasis. The present study was carried out to understand the perceptions of the patients living with psoriasis in relation to their quality of life. Materials and Methods: The Cross-sectional study was conducted on 122 patients of psoriasis irrespective of their age, type, duration, severity of the disease from January 2021 to June 2022 at a tertiary care hospital. Results: Out of 122 patients of psoriasis; 102 were males and 20 were females with male: female ratio of 5.1:1. Mean age of onset of psoriasis in male was 42.9±16.58 years; while in female mean age of onset was a 37.2±15.41 years. Majority of the patients (22.95%) were in the age group of 31 to 40 years. Majority of the patients in the study group had disease duration of more than 5 years. Most common type of psoriasis was chronic plaque psoriasis (72.94%) followed by scalp psoriasis (9.02%), acute guttate psoriasis (6.56%), palmoplanter psoriasis (4.92%), flexural psoriasis (3.28%) pustular and erythrodermic psoriasis (1.64%). History of aggravation of psoriasis was present in various types of stress in 53.28% of the patients. Mean PASI score was 8.9±7.67in the study group.38.53% patients had mild, 25.41% had moderate and 36.06% had severe psoriasis. Mean DLQI score was 8.27±6.10 in the study group. Psoriasis had small effect on QOL in 35.25%, moderate effect in 25.41%, very large effect in 27.87% and extremely large effect in 4.92% of the patients. There was a significant correlationship between the PASI score & DLQI. Conclusion: This study concluded that, psoriasis has got a very significant negative impact on patient’s quality of life and emphase that it is very important to evaluate the QOL in all patients of psoriasis and identify associated psychological distresses like Anxiety and Depression at the time of making therapeutic decision. Key Word: Psoriasis, PASI, DLQI
Downloads
How To Cite (APA)
Dr.Awani Kansagra, Dr Vishal Patel, Dr Kishor Singh, Dr Kavita Choudhary, & Dr U.S.Agarwal (October-2022). DLQI and PASI in patients of psoriasis attending tertiary care centre.. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 7(10), 416-425. https://ijnrd.org/papers/IJNRD2210179.pdf
Issue
Volume 7 Issue 10, October-2022
Pages : 416-425
Other Publication Details
Paper Reg. ID: IJNRD_183084
Published Paper Id: IJNRD2210179
Downloads: 000121985
Research Area: Medical Science
Country: Rajkot,Gujarat, Gujarat, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2210179.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2210179
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
